Overexpression of mRNA-binding protein CRD-BP in malignant melanomas

Oncogene. 2008 Aug 28;27(37):5069-74. doi: 10.1038/onc.2008.141. Epub 2008 May 5.

Abstract

Wnt/beta-catenin signaling pathway plays an important role in embryogenesis, stem cell maintenance, tumorigenesis and aging. Here, we show that RNA-binding protein, coding region determinant-binding protein (CRD-BP) (a transcriptional target of Wnt signaling pathway), is highly expressed in primary human malignant melanomas and melanoma cell lines with activated Wnt/beta-catenin signaling pathway. Upregulation of CRD-BP is associated with an elevated level of beta-TrCP1 ubiquitin ligase receptor and activation of nuclear transcriptional factors-kappa B (NF-kappaB) signaling. Knockdown of CRD-BP inhibits NF-kappaB activity, induces apoptosis, and suppresses proliferation and tumorigenic properties of melanoma cells.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Cell Proliferation / drug effects
  • Gene Expression Regulation, Neoplastic*
  • Humans
  • Melanoma / genetics*
  • Melanoma / metabolism
  • Melanoma / pathology
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • RNA, Messenger / metabolism
  • RNA, Small Interfering / pharmacology
  • RNA-Binding Proteins / antagonists & inhibitors
  • RNA-Binding Proteins / genetics*
  • Transfection
  • Tumor Cells, Cultured
  • Tumor Stem Cell Assay
  • Up-Regulation

Substances

  • IGF2BP1 protein, human
  • NF-kappa B
  • RNA, Messenger
  • RNA, Small Interfering
  • RNA-Binding Proteins